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Objectives: To study the cost effectiveness of Profofol and Thiopental Sodium 
in ICU wards as Induction Anesthetic. while perorming major surgery , anesthe-
sia administration needs an induction agent. The profofol and thiopental sodium 
are alternative as induction anestheatic agents. The efficacy and safety of both 
agents are considered almost equal.However propofol costs 248 INR (approx 4 $)
whereas Thiopental is 68INR(approx 1.2 $). The variation in the price indicates that 
thiopental is a natural choice due to price advantage. However propofol is more 
popular choice of anesthesia as it is vigorously marketed. in order to establish 
the value of thiopental the following study was carried out. MethOds: The study 
was approved by Human ethics commitee, KMC hospital, Manipal. The patients 
who were going on anesthesia procedure were included in the study. However the 
choice of the anesthetic to be used is at the discretion of the anesthesiologist. 43 
patients,( propofol 34 and thiopental 19)were include in the study. The patients were 
administered EQ-5D and the quality of life was computed manually. Additional data 
on socioeconomic status was also collected in order to calculate the cost effective-
ness studies. Results: The data collected was compiled and the cost effectiveness 
of Propofol (N= 32) vs Thiopental N= 19) was calculated using EQ-5d 5L croowalk 
index calculator. THe EQ 5D score for Profofol was 0.228 ±0.298 and for thiopental 
was 0.299±0.211. the ICER was calculated using, “The average cost effectiveness = 
Net Cost/ Net Health Benefit” and it was found be -2535.21. cOnclusiOns: It is 
found that thiopental is cost effective than propofol as ICER for the treatment is 
more than 2535.
SyStemic DiSorDerS/conDitionS – Patient-reported outcomes & Patient 
Preference Studies
PSy7
UnDerStanDing the JaPaneSe general PUblic’S rationale for traDeS 
in a time-traDe-off aSSeSSment for SyStemic lUPUS erythematoSUS
Crawford B.1, Kim H.R.2, Wada K.1
1Adelphi Values, Tokyo, Japan, 2The University of Tokyo, Tokyo, Japan
Objectives: There is a growing need to evaluate utilities for disorders within the 
Asian region to be used in cost-effectiveness analyses. However, there has been 
some concern about the legitimacy of direct utility elicitation among Asian subjects. 
To understand the thinking of subjects responding to a time-trade-off assessment, 
subjects were asked to describe what they considered when making their trade. 
Understanding their rationale will provide insights into the values of respond-
ents. MethOds: Utility and demographic data were collected from 101 subjects 
from the general public in Tokyo. Subjects responded to six hypothetical systemic 
lupus erythematosus health states, described by six levels of severity, and provided 
their valuation of their utility through a visual analog scale and time-trade-off. One 
health state was randomly selected (excluding the anchor state) for each respondent 
to provide their rationale for their trade. Results: Respondents were comprised 
of 54 men and 47 women. Subjects provided a range of responses from concerns of 
family burden to self-preservation (“Prefer to live as long as possible”) and needing 
to finish personal commitments and “Dignity / Pride” by not wanted to ask others for 
any assistance. “Unable to bear symptoms / Prefer to die” was the most frequently 
provided response (~30%) followed by “Burden on family / others” (~20%). Subjects 
who responded to the mild health state had a tendency to respond “Able to tolerate 
symptoms” over other reasons when assessing their trade. Younger subjects were 
more likely to respond with “Hope for a cure”. cOnclusiOns: Our study found that 
subjects were able to provide valid utility estimates from the time-trade-off. The 
rationale for trade-offs provide insights into how responses are formulated within 
an Asian country. Additional research will need to be conducted to compare these 
results to other Asian and Western countries.
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Objectives: The objectives of this study were to investigate the prevalence of neu-
ropathic pain(NP) among patients scheduled for lumbar spinal surgery and the rela-
tionship between health-related quality of life(HRQoL) and NP. This study also aimed 
to identify the risk factors related to NP and compare the clinical outcomes and 
impact on the HRQoL after surgical treatment between patients with and without 
NP. MethOds: This study was a nationwide, multicentered, cross-sectional, observa-
tional study. It was conducted from September 2011 to May 2013, and included a total 
of 1,109 patients who were scheduled for lumbar spinal surgery from 44 spinal centers 
(both orthopaedics and neurosurgeons). Patients were diagnosed of having NP if the 
Leeds Assessment of Neuropathic Symptoms and Signs(LANSS) pain scale criteria was 
≥ 12 points. The patients were investigated to assess the differences in their clinical 
outcomes after 3 months of the surgery and were followed up with regards to pain and 
HRQoL to explore the risk factors affecting NP. Results: Of 1,109 recruited patients, 
404(36.4%) suffered from NP(mean age 62.1 years; 37.9% male) with mean LANSS score 
of 17.4±4.1, while 705(63.6%) had nociceptive pain with mean LANSS score of 6.0±3.5. 
Female and longer symptom duration were identified as risk factors for NP (OR 1.291 
and 1.003, respectively, p< 0.05). At baseline, patients with NP showed lower HRQoL 
and more severe pain compared to nociceptive pain patients. However, 3 months 
after surgical treatment, NP group showed greater improvement in pain(p= 0.087) and 
HRQoL(p= 0.029) as compared to nociceptive pain group. cOnclusiOns: There was 
a high prevalence of NP in Korean patients scheduled for lumbar spine surgery, and 
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Objectives: The metabolic disorder begins with signs of overweight.If un 
attended it leads to metobolic syndrome with Hypertension and Diabetes. The 
polyherbal formulation based on Ayurvedic principles used in this study in the 
management of over weight. The polyherbal formulation consisits of Triphala, 
Guduchi and Mandor basma(TGMB). MethOds: Study design is randomised single 
blind compartive method. Total number of patients in both arms were 40 (20 each) 
were adminstered. The control group were adminstred Guggulu and treatement 
group recived TGMB for 45 days. The parameters observed include monitoring of 
BMI,Lipid Profile, Blood sugars. Results: Before treatement (BT)Average BMI of 
control(C)/treatement(T) group was 28.1/28;After treatement( AT), C 26.59/T 26.79; 
The total cholestrol* BT were C183.54 / T 179.93 : AT C 177.1/ T 174.4; Triglycerides* 
BT C 138.3/ T 129.6: AT C119.9 / T 116.1; HDL* BT C 44.17/ T 40.87: AT C 45.04/ T 41.13 
and Blood sugar* BT C 92 / T94.93 : AT 97.29/95.4 “ *(mg/dl). cOnclusiOns: The 
results indicate the marginal efficacy of control group over treatement group, in 
reducing the BMI and clinical parametrs. However the TGMB was enriched with 
phytomedicines and mineral than Guggulu.
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Objectives: This observational study was designed to determine the prescrib-
ing pattern, improvement of pain intensity, and disability in female patients with 
CLBP. MethOds: In this prospective observational study, female patients suffering 
from back pain for > 12 weeks were enrolled from a public tertiary care hospital in 
north India. Patients with failed back surgery syndrome and other concurrent pain 
conditions were excluded. Data regarding drugs prescribed, pain score assessed by 
visual analogue scale (VAS) and disability assessed by Ostwerty low back pain dis-
ability questionnaire (ODQ) collected at baseline, 3, 6 and 12 months. Effectiveness 
of pharmacotherapy assessed as improvement in pain score and disability at 3, 6 and 
12 months of follow-up. One way repeated measures anova model used to assess 
the change in pain and disability scores. Results: Total 131 female patients of 
mean age 46.2(11.2) years with BMI 22.5(5.73) were included in the study. At baseline, 
duration of CLBP found to be 24 (12-60) months. At the baseline patients on mono 
therapy 27%, Dual 45% and, multiple 28%. Overall prescribed drugs are, Pregabalin 
(82%), Amirtiptyline (64%), Duloxetine (59%), Tramadol (42%), Nortiptyline (36%), 
topical analgesics (75%), Calcium&vitamin supplements (35%), Physical exercises 
and posture advices (75%). During the period of follow-up switching of therapy 
occurred for reasons like low effectiveness and reduced pain intensity etc. When 
compared to baseline, there is a significant (P< 0.05) reduction in pain score (70 
(50-90) vs 40 (25-50)) and disability (51(42-62) vs 22 (16-32)) observed at the end of 
12 months of follow-up. Over the period of follow-ups, we found the significant 
improvement in pain (P< 0.01) and disability (P< 0.023). cOnclusiOns: Our study 
findings concluded that pharmacological treatment, posture and physical exercises 
could be helpful in managing pain and improving of disability in CLBP patients.
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Objectives: Iron deficiency (ID) and iron deficiency anaemia (IDA) are serious 
co-morbidities that arise in several clinical situations and have significant health 
impacts. It amplifies underlying chronic conditions increasing the risk of hospitali-
sations, cost of the disease management and increase risk of mortality. Oral iron 
is mostly the first line treatment for iron deficiency, however it sometimes cannot 
be tolerated due to its side effects, responds relatively slowly, or cannot be used in 
certain chronic conditions. Intravenous iron demonstrated the trends to reduce 
transfusion needs, lower mortality risk, and shorter hospital stay. [1] [2] [3] The 
objective of the study was to estimate the direct health care costs of available intra-
venous iron in Singapore; ferric carboxymaltose (FCM), iron sucrose (IS) and blood 
transfusion for patients with IDA in Singapore. The assessment was made from 
the third party perspective represented by the Department of Medicine, National 
University Hospital Singapore. MethOds: A cost-minimisation analysis compared 
1000mg FCM (1 visit, 15 minutes per visit) versus IS (5 visits, 60 minutes per visit) 
versus the current practice of 2 units of blood transfusion followed by oral adminis-
tration for 3-6 months. The cost was based on the average daily hospitalisation costs 
from the institution. Results: The utilisation of FCM increased administration 
efficiency and optimised health care resources by reducing the number of consulta-
tion visits, time to administer 1000mg of iron, and the average amount required to 
correct IDA. Administering the most cost-efficient option was estimated to save the 
health care system SGD1022 per patient (FCM vs blood transfusion). cOnclusiOns: 
A single dose of 1,000mg FCM is more cost-efficient than IS, blood transfusion only, 
and blood transfusion combined with oral iron for the treatment of IDA in Singapore.
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